丹德罗宾A抑制胃癌:由综合证据支持的机制见解
Yonghao Fan1, Yan Chen2, Wenyan Lu2
1Key Laboratory of Emergency and Trauma of Ministry of Education, Engineering Research Center for Hainan Biological Sample Resources of Major Diseases, the Hainan Branch of National Clinical Research Center for Cancer, the First Affiliated Hospital, Hainan Medical University, Haikou 571199, China; Department of General Medicine, West China Lecheng Hospital of Sichuan University, Boao 571400, China.
概括
丹德罗宾A是一种来自Dendrobium nobile的化合物,通过向HSP90AB1/CDK2/PARP1并调节P53/PI3K-Akt通路,具有显著的抗胃癌 (GC) 作用,具有治疗潜力.
科学领域:
- 癌症学
- 药理学
- 生物信息学
背景情况:
- 传统中医药 (TCM) 具有抗瘤特性,但其分子基础需要阐明.
- 胃癌仍然是一个重大的全球健康挑战,需要新的治疗策略.
- 丹德罗宾A是一种来自Dendrobium nobile的双化合物,具有潜在的抗癌活性.
研究的目的:
- 研究丹德罗宾A在胃癌中的抗癌机制.
- 确定受丹德罗宾A影响的关键分子标和途径.
- 评估丹德罗宾A对胃癌的治疗潜力.
主要方法:
- 对TCGA-STAD数据和网络药理学进行综合生物信息分析,以预测Dendrobin A目标.
- 机器学习和丰富分析以确定关键信号通路 (P53,PI3K-Akt).
- 在体外测试和体外外移植模型中评估Dendrobin A的抗瘤功效和分子作用.
主要成果:
- 在GC中与差异表达基因交叉的Dendrobin A点,涉及P53和PI3K-Akt通路.
- HSP90AB1,CDK2和PARP1被确定为登德罗宾A的主要点.
- 丹德罗宾A抑制了GC细胞的增殖,诱导细胞循环停止,促进了细胞亡,并在体内减少了瘤的生长.
结论:
- 丹德罗宾A具有强大的抗胃癌活性.
- 抗癌作用通过抑制HSP90AB1/CDK2/PARP1和调节P53/PI3K-Akt信号传递.
- 丹德罗宾A可以作为一种治疗胃癌的新药.
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K